Financial Daily from THE HINDU group of publications
Tuesday, January 22, 2002
Markets (Jan. 21)
BL 2501000.80 (+0.76)
BSE Sensex3382.29 (+5.24)
S&P CNX Nifty1091.35 (-1.80)
Dollar (Buy/Sell)48.21/48.34
Gold Std (10gm)4720 (-15)
News
Features
Stocks
Port Info
Archives


Group Sites

HOME PAGE

SEBI panel moots early IPOs by MNCs, banks
IN a bid to revive the sagging primary markets, a Securities and Exchange Board of India (SEBI) panel has suggested ensuring multinational companies and banks that are required to dilute their equity, to do so now. The SEBI panel on primary ... More

DCA relaxes norms for differential voting rights
IN a move that would expedite the issuance of more shares with differential rights as to dividend or voting in the corporate sector, the Union Government has relaxed the existing norms governing the issuance of such shares. The Department of ... More

Satyam Computer posts 36 pc rise in Q3 net
SATYAM Computer Services Ltd has recorded a total income of Rs 446 crore (Rs 332.27 crore) and a net profit of Rs 119 crore (Rs 87.50 crore) for the third quarter ended December 31, registering an increase of 34 per cent in revenue and 36 per ... More

Tata Tea Q3 net up at Rs 20.67 cr
TATA Tea Ltd has ended the third quarter with an increase in net profit at Rs 20.67 crore as compared to Rs 16.45 crore in the year-ago period. During the quarter, the company earned a profit of Rs 7.01 crore from sale of shares in Tata NYK. ... More

BSES places hurdles in DPC bidding process
JUST as the bidding process for Dabhol Power Company (DPC) appeared to take off, BSES Ltd has raised objections to certain clauses in the confidentiality agreement. Refusing to specify the clauses, a top BSES official said: "Both Tata Power and ... More

Scientists deny Pak claims on `infested' wheat
SCIENTISTS at the Indian Council of Agricultural Research (ICAR) have refuted Pakistan's claim about Indian wheat being infested by Karnal Bunt (KB) disease. "There has been no outbreak of KB in our wheat during the last five years. The last ... More

Cadila to launch Fosinopril
CADILA Pharmaceuticals Ltd (CPL) is preparing for a nation-wide launch of Fosinopril, its ACE inhibitor with compensatory dual route. Fovas, the cardio-vascular drug, launched in Ahmedabad this month, will be rolled out in the rest of the ... More

Comments & Letters to the Editor to: bleditor@thehindu.co.in

Praxis New!

Top Stories
A fired-up Singareni Collieries looks at currency swap option

SEBI panel moots early IPOs by MNCs, banks
Collective investment schemes -- SEBI relaxes norms for provisional registration
AMP Sanmar takes the field with Steve Waugh
Scientists deny Pak claims on `infested' wheat
El Nino staging comeback?
AP to rope in private cos for Govt IT projects
In Depth
Inside Kashmir
Guide to derivatives
US-64
Looking back
Jan. 13-Jan. 19
Motorola, HP may strike deals with Reliance Comm
`Pak must walk the talk'
Plan for submarine repair yards
International long-distance for domestic cos -- DoT prescribes Rs 25-cr entry fee
Tatas, Hughes call off talks for basic merger
Modest hike in rail fares likely
Banks may `lose interest' in cos
Maruti second stage sell-off deferred
Role for foreign airlines in management -- FDI in aviation may be hiked to 49 pc
US-64 outperforms Sensex with NAV
Wipro posts 17 pc rise in Q3 net
Bank privatisation efforts faltering

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line